首页> 外国专利> COMPOSITION FOR TREATING ACUTE ASTHMA CAUSED BY VIRUS INFECTION CAPABLE OF SOOTHING CELL INFLAMMATION

COMPOSITION FOR TREATING ACUTE ASTHMA CAUSED BY VIRUS INFECTION CAPABLE OF SOOTHING CELL INFLAMMATION

机译:用于治疗可缓解细胞炎症的病毒感染引起的急性哮喘的药物组合物

摘要

PURPOSE: A composition for treating acute asthma caused by virus infection is provided to control increase of inflammation cell inside bronchoalveolar lavage fluid and airway resistance.;CONSTITUTION: A composition for treating acute asthma caused by virus infection includes AS-605240 as an active ingredient. The acute asthma is induced by processing polyinosinic-polycytidylic acid. The AS-605240 suppresses expression of adhesion, inflammation cell, IgE, Th2, cytokine, chemokine, and vascular endothelial growth factor(VEGF). The composition is formulated in pharmaceutical unit dose form by adding pharmaceutically allowed carrier, excipient, or diluent. The composition is administered in effective amount of 0.1-1mg/kg. A health food for preventing or improving acute asthma caused by virus infection includes AS-605240 as an active ingredient.;COPYRIGHT KIPO 2012
机译:目的:提供一种用于治疗由病毒感染引起的急性哮喘的组合物,以控制支气管肺泡灌洗液内炎症细胞的增加和对气道的抵抗力。;组成:一种用于治疗由病毒感染引起的急性哮喘的组合物,其包含AS-605240作为有效成分。急性哮喘是通过加工多肌苷-聚胞苷酸诱导的。 AS-605240抑制粘附,炎症细胞,IgE,Th2,细胞因子,趋化因子和血管内皮生长因子(VEGF)的表达。通过加入药学上允许的载体,赋形剂或稀释剂将组合物配制成药物单位剂型。所述组合物以0.1-1mg / kg的有效量施用。用于预防或改善由病毒感染引起的急性哮喘的保健食品,其有效成分为AS-605240。; COPYRIGHT KIPO 2012

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号